Rocket Doctor AI Reports Strong U.S. Operational Growth in Q3 2026

  • Rocket Doctor AI completed 3,625 U.S. patient visits in July–August 2026, representing 93% of Q2 2026's total visits.
  • U.S. clinical hours reached 1,555 for the two-month period, 78% of Q2 2026's total.
  • Revenue recognition lags due to cash-basis accounting and out-of-network patient visits.
  • Company plans to convert out-of-network patients to in-network status to improve reimbursement rates.

Rocket Doctor AI's operational update highlights strong growth in U.S. patient visits and clinical hours, despite revenue recognition challenges due to cash-basis accounting and out-of-network visits. The company's strategy to convert out-of-network patients to in-network status aims to improve reimbursement rates and provide greater revenue visibility. This move aligns with broader industry trends towards expanding access to high-quality care through telehealth and AI-powered solutions.

Revenue Recognition
How the timing lag between patient visits and revenue recognition will impact financial performance.
Network Expansion
Whether the company can successfully convert out-of-network patients to in-network status to improve reimbursement rates.
Market Penetration
The pace at which Rocket Doctor AI can expand its user base and clinical hours in the U.S. market.